ANVISA

Supriya Lifescience has developed a technique for low-cost manufacturing of Atorvastatin

ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…

Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a…

Anvisa said it was alerted recently by Sao Paulo's Butantan institute that 25 batches, or 12.1 million doses, sent to Brazil had…

According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially

Denies permission to import Bharat Biotech's COVID-19 vaccine Covaxin into the country

Anvisa said that Uniao Quimica, the pharma firm applying for EUA of Sputnik V vaccine, failed to provide adequate assurances on…

Supplies will be prioritised for the public market through a direct procurement by the Government of Brazil, private market will…

Sources say that the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the…

Sameer Kolhe, President, Maypharm Life Sciences highlights that COVID-19 brings some ‘challenging’ markets within reach for the…